Utility of Bronchoscopy in Patients With Haemoptysis and Negative Chest CT Scan (ULYSSES)
Launched by UNIVERSITY OF MILAN · Nov 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ULYSSES trial is studying the use of a procedure called bronchoscopy in patients who are experiencing hemoptysis, which is when someone coughs up blood, but have had a chest CT scan that didn’t show any clear reason for the bleeding. The goal is to see if bronchoscopy can help find out where the bleeding is coming from or if it can detect any hidden cancers. This study is currently looking for participants aged 18 and older who have unexplained hemoptysis and a negative or unclear chest CT scan.
If you decide to participate, you'll undergo a bronchoscopy, which is a procedure that allows doctors to look inside your airways using a thin, flexible tube. This trial aims to gather more information about the benefits of bronchoscopy in these situations, and it may help improve future care for patients with similar symptoms. It’s important to note that people with known bleeding issues in the airways or those who have already had a chest CT scan that clearly identifies the cause of the bleeding cannot participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years old
- • Haemoptysis of unknown origin
- • Negative or non-diagnostic chest CT scan
- Exclusion Criteria:
- • Known bleeding lesions of the upper or lower respiratory airways
- • Chest CT scan diagnostic for hemoptysis etiology
- • Refusal to sign the informed consent
- • Refusal of bronchoscopy
About University Of Milan
The University of Milan is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively sponsors clinical trials aimed at enhancing healthcare outcomes and fostering innovation in medical science. Its research initiatives are guided by a dedication to ethical standards and rigorous scientific methodologies, ensuring that trials not only contribute to the body of knowledge but also prioritize patient safety and well-being. Through its extensive network of researchers and clinicians, the University of Milan plays a pivotal role in translating scientific discoveries into practical applications that benefit communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Roskilde, , Denmark
Bergamo, , Italy
Bologna, , Italy
Lodi, , Italy
Milan, , Italy
Milan, , Italy
Monza, , Italy
Pavia, , Italy
Roma, , Italy
Torino, , Italy
Barcelona, , Spain
Como, , Italy
Milan, , Italy
Naples, , Italy
Reggio Emilia, , Italy
Udine, , Italy
Patients applied
Trial Officials
Michele Mondoni, MD
Principal Investigator
Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials